Naproxen Special Concept Development (Uk) (Naproxen Bp)

Naproxen works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By decreasing prostaglandin production, naproxen reduces the inflammatory response, diminishes pain signaling, and helps lower elevated body temperature.

The appropriate dose of naproxen is determined by the prescribing healthcare professional based on the specific indication, patient age, weight, renal and hepatic function, and overall clinical condition. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Naproxen is generally classified as a pregnancy category that should be avoided, especially in the third trimester, due to potential risks to the fetus. It is also excreted in breast milk, and caution is advised for nursing mothers. Consultation with a healthcare provider is essential before use in these situations.

To place an order, visit the product page on gnhindia.com, submit an enquiry with the required quantity, and provide institutional or trade credentials. GNH India’s team will verify the information, then respond with pricing, availability, shipping details, and any necessary import documentation.

Both naproxen and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen has a longer half‑life, allowing less frequent dosing, while ibuprofen generally requires multiple daily doses. The choice between them depends on the clinical scenario, patient tolerance, and physician preference.

The product should be stored at room temperature, below 25 °C, in its original packaging. It must be kept away from moisture, direct sunlight, and sources of heat to maintain its stability and potency throughout its shelf life.

Naproxen is administered orally, typically as a tablet or capsule, and should be taken with a full glass of water. It can be taken with food or milk to reduce potential gastrointestinal irritation, but patients should follow the specific instructions provided by their prescriber.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe renal impairment, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should be monitored for these events, especially if they have pre‑existing risk factors.

Naproxen should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulcer or bleeding, severe heart failure, uncontrolled hypertension, and in the third trimester of pregnancy. It is also contraindicated in patients with significant renal or hepatic impairment unless specifically directed by a physician.